Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05874674
NA
The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study
Sponsor: Wonju Severance Christian Hospital
View on ClinicalTrials.gov
Summary
Comparison nafamostat and low molecular weight heparin among dialysis patients
Official title: The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Diathesis Undergoing Hemodialysis: A Pilot Study
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2023-12-01
Completion Date
2026-12-31
Last Updated
2024-07-30
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Nafamostat Mesylate
Comparison effect of nafamostat and cnoxan
Locations (1)
Yonsei Unviersity Wonju College of Medicin
Wŏnju, Kangwondo, South Korea